| Financial Year |
March 31 2023 |
| Monetary Funds |
105,246,943.05 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
31,779,180.21 |
| Accounts Receivable |
128,665,202.91 |
| Advances to Suppliers |
6,814,802.70 |
| Other Receivables |
3,851,568.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
135,340,930.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,794,110.03 |
| Total Current Assets |
413,492,737.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
211,032,122.38 |
| Investment Properties |
-- |
| Fixed Assetes |
200,645,292.33 |
| Under-construction Projects |
1,163,441.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,356,721.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
58,606.12 |
| Deferred Income Tax Assets |
5,752,057.03 |
| Other Non-Current Assets |
13,707,020.00 |
| Sub-Total of Non-Current Assets |
443,715,260.56 |
| Total Assets |
857,207,998.47 |
| Short-Term Loans |
511,393,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,228,705.89 |
| Accounts Payable |
175,215,446.90 |
| Accounts Received In Advance |
3,977,755.15 |
| Employee Compensation Payable |
6,426,230.93 |
| Taxes Payable |
16,582,823.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,594,232.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
771,418,695.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
924,223.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
924,223.98 |
| Total Liabilities |
772,342,919.13 |
| Paid-In Capital(Or Share Stock) |
119,375,000.00 |
| Capital Surplus |
958,565,294.29 |
| Surplus Reserve |
125,686,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,122,497,671.13 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
84,865,079.34 |
| Owner's Equity（Stockholder's Equity） |
84,865,079.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
857,207,998.47 |
